Hudson Bay Capital
A New York-based hedge fund that provides management services.
All edits
Edits on 9 Feb, 2020
Edits made to:
Article (+15/-15 characters)
Article
Hudson Bay Capital Management is a hedge fund in New York that that provides management services. Founded 2005 in New York, United States, the company invests in Series B roundsSeries B rounds. Hudson Bay Capital Management has invested in Alphamab Oncology on May 28, 2019. This investment in the Series B round of Alphamab Oncology was valued at $60M. Alphamab Oncology is a clinical-stage biopharmaceutical company. Hudson Bay Capital Management later exited this company.
Edits on 8 Feb, 2020
Edits made to:
Article (+6/-6 characters)
Article
The company is a multi-billion dollar asset management firm operating in New York and LondonLondon. Hudson Bay Capital is the successor to Gerber Asset Management LLC, a proprietary investment firm established by Hudson Bay’s founder Sander Gerber.
Edits made to:
Article (+13/-13 characters)
Article
Hudson Bay Capital Management is a hedge fund in New York that that provides management services. Founded 2005 in New York, United StatesUnited States, the company invests in Series B rounds. Hudson Bay Capital Management has invested in Alphamab Oncology on May 28, 2019. This investment in the Series B round of Alphamab Oncology was valued at $60M. Alphamab Oncology is a clinical-stage biopharmaceutical company. Hudson Bay Capital Management later exited this company.
Edits made to:
Description (+63/-86 characters)
Article (+705 characters)
Hudson Bay Capital
Hudson Bay Capital is an asset management firm that operates in New York and London.
A New York-based hedge fund that provides management services.
Article
Hudson Bay Capital Management is a hedge fund in New York that that provides management services. Founded 2005 in New York, United States, the company invests in Series B rounds. Hudson Bay Capital Management has invested in Alphamab Oncology on May 28, 2019. This investment in the Series B round of Alphamab Oncology was valued at $60M. Alphamab Oncology is a clinical-stage biopharmaceutical company. Hudson Bay Capital Management later exited this company.
The company is a multi-billion dollar asset management firm operating in New York and London. Hudson Bay Capital is the successor to Gerber Asset Management LLC, a proprietary investment firm established by Hudson Bay’s founder Sander Gerber.
Edits on 3 Feb, 2020
Edits made to:
Infobox (+4 properties)
Timeline (+1 events) (+7 characters)
People (+4 rows) (+8 cells) (+239 characters)
Companies (+1 rows) (+1 cells) (+17 characters)
People
Name
Role
LinkedIn
Sander Gerber
Chief Executive Officer / Chief Investment Officer
Charles Winkler
Senior Managing Director / Chief Operating Officer
Roy Astrachan
Senior Managing Director / Portfolio Manager
Yoav Roth
Managing Director / Portfolio Manager
Companies
Company
CEO
Location
Products/Services
Alphamab Oncology
Infobox
Location
Founded date
2005
Invested in
Timeline
2005
Founded
Edits on 15 Oct, 2019
Edits made to:
Infobox (+1 properties)
Article
Article
Edits on 5 Jun, 2019
Edits made to:
Description (+86 characters)
Categories (+1 topics)
Hudson Bay Capital
Hudson Bay Capital is an asset management firm that operates in New York and London.
Categories
Cluster: Venture capitalEdits on 30 May, 2019
Edits made to:
Infobox (+4/--1 properties)
Infobox
Edits made to:
Hudson Bay Capital
A New York-based hedge fund that provides management services.
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.